Source: The Hematology Journal. Conference titles: Annual Meeting of the European Hematology Association. Unidade: FMRP
Subjects: INFARTO DO MIOCÁRDIO, HEMATOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FRANCO, Rendrik França et al. Gene polymorphisms in the thrombin activatable fibrinolysis inhibitor (TAFI) and the risk of myocardial infarction. The Hematology Journal. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 16 nov. 2024. , 2002APA
Franco, R. F., Meijers, J. C. M., Pazin-Filho, A., Simões, M. V., Marin-Neto, J. A., Tavella, M. H., et al. (2002). Gene polymorphisms in the thrombin activatable fibrinolysis inhibitor (TAFI) and the risk of myocardial infarction. The Hematology Journal. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.NLM
Franco RF, Meijers JCM, Pazin-Filho A, Simões MV, Marin-Neto JA, Tavella MH, Araújo AG, Reitsma PH, Zago MA. Gene polymorphisms in the thrombin activatable fibrinolysis inhibitor (TAFI) and the risk of myocardial infarction. The Hematology Journal. 2002 ; 3 102 res. 0321.[citado 2024 nov. 16 ]Vancouver
Franco RF, Meijers JCM, Pazin-Filho A, Simões MV, Marin-Neto JA, Tavella MH, Araújo AG, Reitsma PH, Zago MA. Gene polymorphisms in the thrombin activatable fibrinolysis inhibitor (TAFI) and the risk of myocardial infarction. The Hematology Journal. 2002 ; 3 102 res. 0321.[citado 2024 nov. 16 ]
